Valve ‐in‐valve transcatheter aortic valve implantation with CoreValve/Evolut R© for degenerated small versus bigger bioprostheses

ConclusionViV‐TAVI with CoreValve/R is demonstrated to be safe and effective in terms of no coronary obstruction and very low mortality up to 3 years despite slightly higher mean transprosthetic gradients especially in very small bioprostheses.

Source: Journal of Interventional Cardiology - February 28, 2018 Category: Cardiology Authors: Smita Scholtz, Cornelia Piper, Dieter Horstkotte, Jan Gummert, Stephan M. Ensminger, Jochen B örgermann, Werner Scholtz Tags: ORIGINAL INVESTIGATION Source Type: research